JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M206942200 on November 8, 2002

J. Biol. Chem., Vol. 278, Issue 3, 1647-1655, January 17, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/3/1647    most recent
M206942200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gronow, S.
Right arrow Articles by Brade, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gronow, S.
Right arrow Articles by Brade, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Construction of a Deep-rough Mutant of Burkholderia cepacia ATCC 25416 and Characterization of Its Chemical and Biological Properties*

Sabine GronowDagger §, Christian NoahDagger , Antje Blumenthal, Buko Lindner||, and Helmut BradeDagger

From the Divisions of Dagger  Medical and Biochemical Microbiology,  Molecular Infection Biology, and || Biophysics, Research Center Borstel, Center for Medicine and Biosciences, Parkallee 22, D-23845 Borstel, Germany

Burkholderia cepacia is a bacterium with increasing importance as a pathogen in patients with cystic fibrosis. The deep-rough mutant Ko2b was generated from B. cepacia type strain ATCC 25416 by insertion of a kanamycin resistance cassette into the gene waaC encoding heptosyltransferase I. Mass spectrometric analysis of the de-O-acylated lipopolysaccharide (LPS) of the mutant showed that it consisted of a bisphosphorylated glucosamine backbone with two 3-hydroxyhexadecanoic acids in amide-linkage, 4-amino-4-deoxyarabinose (Ara4N) residues on both phosphates, and a core oligosaccharide of the sequence Ara4N-(1 right-arrow 8) D-glycero-D-talo-oct-2-ulosonic acid (Ko)-(2 right-arrow 4)3-deoxy-D-manno-oct-2-ulosonic acid (Kdo). The mutant allowed investigations on the biosynthesis of the LPS as well as on its role in human infection. Mutant Ko2b showed no difference in its ability to invade human macrophages as compared with the wild type. Furthermore, isolated LPS of both strains induced the production of tumor necrosis factor alpha  from macrophages to the same extent. Thus, the truncation of the LPS did not decrease the biological activity of the mutant or its LPS in these aspects.


* This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 470/A1 (to H. B. and S. G.) and LI 448/1-1 (to B. L.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AJ302064 and AJ420777.

§ To whom correspondence should be addressed: Division of Medical and Biochemical Microbiology Research Center Borstel, Center for Medicine and Biosciences, Parkallee 22, D-23845 Borstel, Germany. Tel.: 49-4537-188469; Fax: 49-4537-188419; E-mail: sgronow@fz-borstel.de.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Innate ImmunityHome page
A. De Soyza, A. Silipo, R. Lanzetta, J. R. Govan, and A. Molinaro
Review: Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides
Innate Immunity, June 1, 2008; 14(3): 127 - 144.
[Abstract] [PDF]


Home page
J. Bacteriol.Home page
X. P. Ortega, S. T. Cardona, A. R. Brown, S. A. Loutet, R. S. Flannagan, D. J. Campopiano, J. R. W. Govan, and M. A. Valvano
A Putative Gene Cluster for Aminoarabinose Biosynthesis Is Essential for Burkholderia cenocepacia Viability
J. Bacteriol., May 1, 2007; 189(9): 3639 - 3644.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
S. A. Loutet, R. S. Flannagan, C. Kooi, P. A. Sokol, and M. A. Valvano
A Complete Lipopolysaccharide Inner Core Oligosaccharide Is Required for Resistance of Burkholderia cenocepacia to Antimicrobial Peptides and Bacterial Survival In Vivo
J. Bacteriol., March 15, 2006; 188(6): 2073 - 2080.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
S. Gronow, W. Brabetz, B. Lindner, and H. Brade
OpsX from Haemophilus influenzae Represents a Novel Type of Heptosyltransferase I in Lipopolysaccharide Biosynthesis
J. Bacteriol., September 1, 2005; 187(17): 6242 - 6247.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
A. Silipo, A. Molinaro, P. Cescutti, E. Bedini, R. Rizzo, M. Parrilli, and R. Lanzetta
Complete structural characterization of the lipid A fraction of a clinical strain of B. cepacia genomovar I lipopolysaccharide
Glycobiology, May 1, 2005; 15(5): 561 - 570.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Shimomura, M. Matsuura, S. Saito, Y. Hirai, Y. Isshiki, and K. Kawahara
Unusual Interaction of a Lipopolysaccharide Isolated from Burkholderia cepacia with Polymyxin B
Infect. Immun., September 1, 2003; 71(9): 5225 - 5230.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.